XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Impact of adoption of ASC 326
Common Stock
Capital In Excess of Par Value
Retained Earnings
Retained Earnings
Impact of adoption of ASC 326
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Balances at Dec. 31, 2018 $ 10,161   $ 33 $ 2,535 $ 15,072   $ (159) $ (7,320)
Balances (in shares) at Dec. 31, 2018     198,595          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 2,195       2,195      
Other comprehensive income (loss) 336           336  
Common stock repurchases (1,010)     (50)       (960)
Dividends and dividend equivalents (222)       (222)      
Stock-based compensation 119     119        
Restricted stock unit vesting 0     (3)       3
Restricted stock unit vesting (in shares)     32          
Stock option exercises 22     7       15
Stock option exercises (in shares)     2          
Balances at Sep. 30, 2019 11,601   $ 33 2,608 17,045   177 (8,262)
Balances (in shares) at Sep. 30, 2019     198,629          
Balances at Dec. 31, 2018 10,161   $ 33 2,535 15,072   (159) (7,320)
Balances (in shares) at Dec. 31, 2018     198,595          
Balances at Dec. 31, 2019 $ 12,037 $ (2) $ 33 2,820 17,483 $ (2) 156 (8,455)
Balances (in shares) at Dec. 31, 2019     198,630          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member              
Balances at Jun. 30, 2019 $ 11,872   $ 33 2,763 16,429   112 (7,465)
Balances (in shares) at Jun. 30, 2019     198,628          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 689       689      
Other comprehensive income (loss) 65           65  
Common stock repurchases (1,000)     (200)       (800)
Dividends and dividend equivalents (73)       (73)      
Stock-based compensation 43     43        
Restricted stock unit vesting 0     0       0
Restricted stock unit vesting (in shares)     0          
Stock option exercises 5     2       3
Stock option exercises (in shares)     1          
Balances at Sep. 30, 2019 11,601   $ 33 2,608 17,045   177 (8,262)
Balances (in shares) at Sep. 30, 2019     198,629          
Balances at Dec. 31, 2019 12,037 $ (2) $ 33 2,820 17,483 $ (2) 156 (8,455)
Balances (in shares) at Dec. 31, 2019     198,630          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 3,641       3,641      
Other comprehensive income (loss) 214           214  
Common stock repurchases (30)     0       (30)
Common stock repurchases (in shares)     19          
Dividends and dividend equivalents (250)       (250)      
Stock-based compensation 129     129        
Restricted stock unit vesting 0     (21)       21
Restricted stock unit vesting (in shares)     0          
Stock option exercises 29     12       17
Stock option exercises (in shares)     0          
Balances at Sep. 30, 2020 15,768   $ 33 2,940 20,872   370 (8,447)
Balances (in shares) at Sep. 30, 2020     198,649          
Balances at Jun. 30, 2020 14,416   $ 33 2,898 19,616   317 (8,448)
Balances (in shares) at Jun. 30, 2020     198,630          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 1,340       1,340      
Other comprehensive income (loss) 53           53  
Common stock repurchases (5)     0       (5)
Common stock repurchases (in shares)     19          
Dividends and dividend equivalents (84)       (84)      
Stock-based compensation 47     47        
Restricted stock unit vesting 0     (6)       6
Restricted stock unit vesting (in shares)     0          
Stock option exercises 1     1       0
Stock option exercises (in shares)     0          
Balances at Sep. 30, 2020 $ 15,768   $ 33 $ 2,940 $ 20,872   $ 370 $ (8,447)
Balances (in shares) at Sep. 30, 2020     198,649